Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Enzo Biochem Net Income 2006-2020 | ENZ

For a detailed definition, formula and example for Net Income, check out our new background page here.
Enzo Biochem net income from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Enzo Biochem Annual Net Income
(Millions of US $)
2020 $-29
2019 $2
2018 $-10
2017 $-3
2016 $45
2015 $-2
2014 $-10
2013 $-18
2012 $-39
2011 $-13
2010 $-22
2009 $-24
2008 $-11
2007 $-13
2006 $-16
2005 $3
Enzo Biochem Quarterly Net Income
(Millions of US $)
2020-10-31 $0
2020-07-31 $-3
2020-04-30 $-10
2020-01-31 $-8
2019-10-31 $-8
2019-07-31 $-5
2019-04-30 $22
2019-01-31 $-8
2018-10-31 $-6
2018-07-31 $-6
2018-04-30 $-3
2018-01-31 $-1
2017-10-31 $-1
2017-07-31 $0
2017-04-30 $-0
2017-01-31 $-1
2016-10-31 $-1
2016-07-31 $36
2016-04-30 $-2
2016-01-31 $7
2015-10-31 $4
2015-07-31 $8
2015-04-30 $-3
2015-01-31 $-4
2014-10-31 $-4
2014-07-31 $-3
2014-04-30 $-0
2014-01-31 $-4
2013-10-31 $-3
2013-07-31 $-3
2013-04-30 $-6
2013-01-31 $-6
2012-10-31 $-4
2012-07-31 $-27
2012-04-30 $-3
2012-01-31 $-4
2011-10-31 $-4
2011-07-31 $-4
2011-04-30 $-2
2011-01-31 $-6
2010-10-31 $-1
2010-07-31 $-6
2010-04-30 $-5
2010-01-31 $-10
2009-10-31 $-2
2009-07-31 $-5
2009-04-30 $-4
2009-01-31 $-8
2008-10-31 $-6
2008-07-31 $-3
2008-04-30 $-2
2008-01-31 $-4
2007-10-31 $-1
2007-07-31 $-3
2007-04-30 $-4
2007-01-31 $-5
2006-10-31 $-1
2006-07-31 $-5
2006-04-30 $-3
2006-01-31 $-4
2005-10-31 $-3
2005-07-31 $-2
2005-04-30 $-1
2005-01-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.134B $0.076B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $135.392B 9.38
Amgen (AMGN) United States $131.529B 13.72
CSL (CSLLY) Australia $87.969B 0.00
Gilead Sciences (GILD) United States $81.201B 9.11
Illumina (ILMN) United States $58.192B 88.63
Vertex Pharmaceuticals (VRTX) United States $55.106B 23.42
Moderna (MRNA) United States $52.846B 0.00
Regeneron Pharmaceuticals (REGN) United States $49.449B 16.16
Biogen (BIIB) United States $41.239B 8.25
Alexion Pharmaceuticals (ALXN) United States $32.999B 12.85
BeiGene (BGNE) Cayman Islands $27.578B 0.00
Seagen (SGEN) United States $27.057B 46.38
BioNTech SE (BNTX) Germany $23.164B 0.00
Genmab (GMAB) Denmark $20.811B 29.13
Exact Sciences (EXAS) United States $20.568B 0.00
Genmab (GNMSF) Denmark $19.984B 4.74
Horizon Therapeutics Public (HZNP) Ireland $19.862B 22.79
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.827B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.927B 57.05
Incyte (INCY) United States $17.645B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.777B 0.00
ARGENX SE-ADR (ARGX) Netherlands $14.759B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.134B 112.65
Bio-Techne Corp (TECH) United States $13.821B 79.16
Guardant Health (GH) United States $13.585B 0.00
Novavax (NVAX) United States $12.913B 0.00
Zai Lab (ZLAB) China $12.081B 0.00
QIAGEN (QGEN) Netherlands $10.823B 22.10
Repligen (RGEN) United States $10.198B 112.16
Mirati Therapeutics (MRTX) United States $9.650B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.648B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.933B 0.00
Ascendis Pharma (ASND) Denmark $7.847B 0.00
Fate Therapeutics (FATE) United States $7.845B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.839B 0.00
Acceleron Pharma (XLRN) United States $7.738B 0.00
Denali Therapeutics (DNLI) United States $7.385B 234.77
Exelixis (EXEL) United States $6.967B 63.80
Sarepta Therapeutics (SRPT) United States $6.734B 0.00
Adaptive Biotechnologies (ADPT) United States $5.879B 0.00
Vir Biotechnology (VIR) United States $5.776B 0.00
Twist Bioscience (TWST) United States $5.718B 0.00
Blueprint Medicines (BPMC) United States $5.560B 18.31
Halozyme Therapeutics (HALO) United States $5.534B 45.46
Galapagos (GLPG) Belgium $5.475B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $5.203B 0.00
NeoGenomics (NEO) United States $5.058B 617.86
Emergent Biosolutions (EBS) United States $4.920B 11.76
SWEDISH ORP BIO (BIOVF) Sweden $4.791B 15.07
China Biologic Products (CBPO) China $4.635B 30.04
Arena Pharmaceuticals (ARNA) United States $4.439B 0.00
Reata Pharmaceuticals (RETA) United States $4.330B 0.00
Beam Therapeutics (BEAM) United States $4.208B 0.00
Certara (CERT) United States $4.034B 0.00
Insmed (INSM) United States $3.929B 0.00
Apellis Pharmaceuticals (APLS) United States $3.923B 0.00
SpringWorks Therapeutics (SWTX) United States $3.644B 0.00
I-Mab (IMAB) China $3.546B 0.00
Arvinas (ARVN) United States $3.521B 0.00
Intellia Therapeutics (NTLA) United States $3.509B 0.00
Legend Biotech (LEGN) United States $3.235B 0.00
Berkeley Lights (BLI) United States $3.202B 0.00
MorphoSys AG (MOR) Germany $3.184B 115.24
Alkermes (ALKS) Ireland $3.070B 0.00
NantKwest (NK) United States $2.930B 0.00
Viela Bio (VIE) United States $2.910B 0.00
Intra-Cellular Therapies (ITCI) United States $2.805B 0.00
Editas Medicine (EDIT) United States $2.804B 0.00
Amicus Therapeutics (FOLD) United States $2.770B 0.00
Global Blood Therapeutics (GBT) United States $2.546B 0.00
Sorrento Therapeutics (SRNE) United States $2.494B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.466B 0.00
Arcus Biosciences (RCUS) United States $2.411B 0.00
Ligand Pharmaceuticals (LGND) United States $2.399B 45.41
Amarin (AMRN) Ireland $2.329B 0.00
Morphic Holding (MORF) United States $2.273B 0.00
PHARMA MAR SA (PHMMF) Spain $2.211B 0.00
Myriad Genetics (MYGN) United States $2.094B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.091B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.083B 17.25
Vericel (VCEL) United States $1.954B 850.20
Bluebird Bio (BLUE) United States $1.926B 0.00
Inovio Pharmaceuticals (INO) United States $1.908B 0.00
Revance Therapeutics (RVNC) United States $1.877B 0.00
Scholar Rock Holding (SRRK) United States $1.801B 0.00
Genetron Holdings (GTH) China $1.784B 0.00
NGM Biopharmaceuticals (NGM) United States $1.781B 0.00
Pandion Therapeutics (PAND) United States $1.768B 0.00
Seres Therapeutics (MCRB) United States $1.739B 0.00
Precigen (PGEN) United States $1.738B 0.00
REGENXBIO (RGNX) United States $1.697B 0.00
Sangamo Therapeutics (SGMO) United States $1.627B 0.00
Heska (HSKA) United States $1.627B 0.00
Travere Therapeutics (TVTX) United States $1.626B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.567B 0.00
Zymeworks (ZYME) Canada $1.520B 0.00
UniQure (QURE) Netherlands $1.461B 0.00
Five Prime Therapeutics (FPRX) United States $1.436B 0.00
Nurix Therapeutics (NRIX) United States $1.421B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.421B 0.00
Cytokinetics (CYTK) United States $1.399B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.394B 0.00
Castle Biosciences (CSTL) United States $1.390B 0.00
Alector (ALEC) United States $1.359B 0.00
Zealand Pharma (ZEAL) Denmark $1.345B 0.00
Mersana Therapeutics (MRSN) United States $1.271B 0.00
Frequency Therapeutics (FREQ) United States $1.261B 0.00
Codexis (CDXS) United States $1.256B 0.00
MiMedx (MDXG) United States $1.175B 0.00
Coherus BioSciences (CHRS) United States $1.152B 9.37
Zealand Pharma (ZLDPF) Denmark $1.141B 0.00
Northwest Biotherapeutics (NWBO) United States $1.136B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.135B 0.00
Pliant Therapeutics (PLRX) United States $1.118B 0.00
Protagonist Therapeutics (PTGX) United States $1.114B 0.00
Bionano Genomics (BNGO) United States $1.095B 0.00
Adverum Biotechnologies (ADVM) United States $1.087B 0.00
Mesoblast (MESO) Australia $1.078B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.062B 0.00
Celldex Therapeutics (CLDX) United States $1.037B 0.00
Avid Bioservices (CDMO) United States $1.007B 0.00
Repare Therapeutics (RPTX) Canada $1.002B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.001B 42.43
Epizyme (EPZM) United States $0.968B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.964B 0.00
Dynavax Technologies (DVAX) United States $0.932B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.921B 0.00
MannKind (MNKD) United States $0.907B 0.00
Cara Therapeutics (CARA) United States $0.902B 226.13
G1 THERAPEUTICS (GTHX) United States $0.857B 0.00
Prothena (PRTA) Ireland $0.855B 0.00
Pharming Group (PHAR) $0.852B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.822B 0.00
Pharming Group (PHGUF) Netherlands $0.817B 21.75
Sutro Biopharma (STRO) United States $0.815B 0.00
AnaptysBio (ANAB) United States $0.806B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.796B 0.00
Kadmon Holdings (KDMN) United States $0.792B 0.00
Cellectis S.A (CLLS) France $0.778B 0.00
VBI Vaccines (VBIV) United States $0.748B 0.00
Merus (MRUS) Netherlands $0.719B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.713B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.682B 0.00
ALBIREO PHARMA (ALBO) United States $0.666B 0.00
ChromaDex (CDXC) United States $0.663B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.658B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Starpharma Holdings (SPHRY) Australia $0.626B 0.00
Agenus (AGEN) United States $0.608B 0.00
Precision BioSciences (DTIL) United States $0.604B 0.00
Clovis Oncology (CLVS) United States $0.583B 0.00
DBV Technologies S.A (DBVT) France $0.572B 0.00
Compugen (CGEN) Israel $0.568B 0.00
MeiraGTx Holdings (MGTX) United States $0.559B 0.00
Geron (GERN) United States $0.559B 0.00
Curis (CRIS) United States $0.557B 0.00
Inventiva S.A (IVA) France $0.545B 0.00
AC Immune SA (ACIU) Switzerland $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Gritstone Oncology (GRTS) United States $0.512B 0.00
Neoleukin Therapeutics (NLTX) United States $0.510B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.510B 0.00
CytomX Therapeutics (CTMX) United States $0.504B 0.00
Amryt Pharma (AMYT) United Kingdom $0.501B 0.00
Anika Therapeutics (ANIK) United States $0.492B 164.95
Syros Pharmaceuticals (SYRS) United States $0.489B 0.00
AMMO (POWW) United States $0.475B 0.00
WAVE Life Sciences (WVE) Singapore $0.463B 0.00
Affimed (AFMD) Germany $0.461B 0.00
AquaBounty Technologies (AQB) United States $0.451B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.448B 0.00
Spero Therapeutics (SPRO) United States $0.444B 0.00
Kala Pharmaceuticals (KALA) United States $0.438B 0.00
Puma Biotechnology (PBYI) United States $0.437B 0.00
UROGEN PHARMA (URGN) United States $0.415B 0.00
BioDelivery Sciences (BDSI) United States $0.410B 19.29
Selecta Biosciences (SELB) United States $0.409B 0.00
XOMA (XOMA) United States $0.407B 0.00
Athenex (ATNX) United States $0.403B 0.00
Cue Biopharma (CUE) United States $0.395B 0.00
Fulcrum Therapeutics (FULC) United States $0.392B 0.00
Fortress Biotech (FBIO) United States $0.385B 0.00
Opthea (OPT) Australia $0.385B 0.00
Verastem (VSTM) United States $0.377B 0.00
Kaleido Biosciences (KLDO) $0.374B 0.00
Athersys (ATHX) United States $0.366B 0.00
ANI Pharmaceuticals (ANIP) United States $0.365B 9.28
Cardiff Oncology (CRDF) United States $0.360B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.348B 0.00
Forte Biosciences (FBRX) United States $0.343B 0.00
Innate Pharma S.A (IPHA) France $0.340B 0.00
Trevena (TRVN) United States $0.328B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.324B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.323B 0.00
Oncobiologics (OTLK) United States $0.316B 0.00
Arbutus Biopharma (ABUS) United States $0.315B 0.00
NextCure (NXTC) United States $0.312B 0.00
Bellus Health (BLU) Canada $0.301B 0.00
Theratechnologies (THTX) Canada $0.295B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Kamada (KMDA) Israel $0.272B 15.64
HOOKIPA Pharma (HOOK) United States $0.260B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.258B 0.00
CorMedix Inc (CRMD) United States $0.237B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.236B 0.00
Cerecor (CERC) United States $0.232B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.232B 0.00
TELA Bio (TELA) United States $0.232B 0.00
Checkpoint Therapeutics (CKPT) United States $0.225B 0.00
OSMOTICA PHARM (OSMT) United States $0.223B 0.00
INmune Bio (INMB) United States $0.214B 0.00
Voyager Therapeutics (VYGR) United States $0.208B 5.82
Applied Genetic Technologies (AGTC) United States $0.208B 0.00
Aptinyx (APTX) United States $0.202B 0.00
Abeona Therapeutics (ABEO) United States $0.198B 0.00
ADMA Biologics Inc (ADMA) United States $0.198B 0.00
VTv Therapeutics (VTVT) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
Evofem Biosciences (EVFM) United States $0.190B 0.00
Kindred Biosciences (KIN) United States $0.189B 0.00
GENFIT S.A (GNFT) France $0.188B 0.00
Strongbridge Biopharma (SBBP) United States $0.188B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.188B 0.00
Eton Pharmaceuticals (ETON) United States $0.187B 0.00
Exicure (XCUR) United States $0.180B 0.00
Chiasma (CHMA) United States $0.178B 0.00
Nicox SA (NICXF) France $0.177B 0.00
Idera Pharmaceuticals (IDRA) United States $0.176B 0.00
Orgenesis (ORGS) United States $0.173B 358.50
Antibe Therapeutics (ATBPF) Canada $0.168B 0.00
DiaMedica Therapeutics (DMAC) United States $0.161B 0.00
Pluristem Therapeutics (PSTI) Israel $0.157B 0.00
X4 Pharmaceuticals (XFOR) United States $0.155B 0.00
Cogent Biosciences (COGT) United States $0.154B 0.00
Clearside Biomedical (CLSD) United States $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.144B 0.00
Biofrontera AG (BFRA) Germany $0.143B 0.00
Aptevo Therapeutics (APVO) United States $0.142B 0.00
Seelos Therapeutics (SEEL) United States $0.139B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Aytu Bioscience (AYTU) United States $0.133B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.130B 0.00
TRACON Pharmaceuticals (TCON) United States $0.127B 0.00
CytRx (CYTR) United States $0.127B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.124B 0.00
Liminal BioSciences (LMNL) Canada $0.123B 0.00
Cyclerion Therapeutics (CYCN) United States $0.122B 0.00
Synlogic (SYBX) United States $0.119B 0.00
Evogene (EVGN) Israel $0.118B 0.00
Beyond Air (XAIR) United States $0.116B 0.00
Prima BioMed (IMMP) Australia $0.116B 0.00
Liquidia Technologies (LQDA) United States $0.113B 0.00
Cidara Therapeutics (CDTX) United States $0.111B 0.00
Lumos Pharma (LUMO) United States $0.109B 0.00
Ecology Coatings (ABVC) United States $0.107B 0.00
PHASEBIO PHARMA (PHAS) United States $0.105B 0.00
ARAVIVE, INC (ARAV) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.100B 0.00
Cocrystal Pharma (COCP) United States $0.097B 0.00
Adocia (ADOCY) France $0.092B 0.00
Novogen (KZIA) Australia $0.090B 0.00
AIkido Pharma (AIKI) United States $0.087B 0.00
Vascular Biogenics (VBLT) Israel $0.087B 0.00
Stealth BioTherapeutics (MITO) United States $0.079B 35.75
Cleveland BioLabs (CBLI) United States $0.077B 0.00
Advaxis (ADXS) United States $0.076B 0.00
Organovo Holdings (ONVO) United States $0.076B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.074B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.069B 0.00
AEterna Zentaris (AEZS) United States $0.068B 0.00
Edesa Biotech (EDSA) Canada $0.067B 0.00
Emmaus Life Sciences (EMMA) United States $0.066B 0.00
Purple Biotech (PPBT) Israel $0.065B 0.00
AnPac Bio-Medical Science (ANPC) China $0.065B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Celsion (CLSN) United States $0.064B 0.00
Windtree Therapeutics (WINT) United States $0.062B 0.00
Genetic Technologies (GENE) Australia $0.059B 0.00
ZIVO Bioscience (ZIVO) United States $0.059B 0.00
ARIDIS PHARMACT (ARDS) United States $0.056B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Soligenix (SNGX) United States $0.048B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Yumanity Therapeutics (YMTX) United States $0.044B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.044B 0.00
BioCardia (BCDA) United States $0.044B 0.00
ATyr Pharma (LIFE) United States $0.043B 0.00
Enveric Biosciences (ENVB) United States $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.74
Alimera Sciences (ALIM) United States $0.038B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.036B 0.00
IMMURON (IMRN) Australia $0.035B 0.00
Prana Biotechnology (ATHE) Australia $0.031B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
Seneca Biopharma (SNCA) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
GeoVax Labs (GOVX) United States $0.019B 0.00
ThermoGenesis Holdings (THMO) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.017B 0.00
Benitec Biopharma (BNTC) United States $0.013B 0.00
Cyclo Therapeutics (CYTH) United States $0.013B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00